Senate Republicans are moving ahead with their own legislation to relax Food and Drug Administration approval processes and boost medical-research funding, after talks to produce a bipartisan bill broke down.
For weeks, members and staffers of the Senate Health, Education, Labor and Pensions Committee have been trying to find common ground on the legislation. Republicans wanted to smooth the regulatory path for drug and medical device approvals, while Democrats strove to increase funding for medical research and find ways to keep drug prices in check.
Read Full Article »